ArticleEClinicalMedicine2023

The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non-small cell lung cancer with sensitive EGFR mutations.

Yu Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.